NCT02234492View on ClinicalTrials.gov

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Interventions
DRUG

Rosuvastatin

Comparison of rosuvastatin to no rosuvastatin

Trial Locations (2)

K1H 8L6

The Ottawa Hospital-General Campus, Ottawa

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Ontario HIV Treatment Network

NETWORK

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02234492 - The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients | Biotech Hunter | Biotech Hunter